SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
London Stock Exchange
Börse London Stock Exchange
  • Inovio Pharmaceuticals Inc
    Börse Börse Frankfurt
    Symbol GBMB
    EUR
  • Inovio Pharmaceuticals Inc
    Börse Börse Berlin
    Symbol GBMB
    EUR
  • INOVIO PHARMACEUTICALS INC
    Börse Gettex System der Börse München
    Symbol GBMB
    EUR
  • INOVIO PHARMACEUTICALS INC
    Börse Börse Stuttgart
    Symbol GBMB
    EUR
  • INOVIO PHARMACEUTICALS INC
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol GBMB
    EUR
  • INOVIO PHARMACEUTICALS INC
    Börse Börse Düsseldorf
    Symbol GBMB
    EUR
  • INOVIO PHARMACEUTICALS INC
    Börse Quotrix System der Börse Düsseldorf
    Symbol GBMB
    EUR
  • Inovio Pharmaceuticals Inc
    Börse Nasdaq
    ISIN US45773H2013 WKN: A115GK
    Symbol INO
    USD
  • ISIN US45773H2013 WKN: A115GK
    Symbol INO
    USD
  • Inovio Pharmaceuticals Inc
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    MXN
  • Symbol GBMB
    EUR
  • EUR
  • MXN
  • Inovio Pharmaceuticals, Inc.
    Börse London Stock Exchange
Marktkapitalisierung 2.040.357.632 (+- 43%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

2.908.715.264 oder 1.172.000.000

Mitarbeiter 187 (+- 2%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

190 oder 184 Mitarbeiter

EBITDA -108.041.976
Buchwert 1.933

37 News & Informationen zur Inovio Pharmaceuticals Inc Aktie

  • Etsy And NetApp Lead The S&P 500
    benzinga.com

    Etsy And NetApp Lead The S&P 500

    U.S. indices were trading lower Thursday as traders await signs of Fed tapering policy. Explosions outside of Kabul airport in Afghanistan has also caused …

  • Why Inovio's Stock Is Trading Higher Today
    markets.businessinsider.com

    Why Inovio's Stock Is Trading Higher Today

    Inovio Pharmaceuticals Inc (NASDAQ:INO) is trading higher Thursday after the company announced it received regulatory authorization from Braz…

  • Inovio Pharmaceuticals Inc (INO): Price Up $0.2 (2.36)% Over Past Day, Up $0.03 (0.35)% Over Past Hour
    etfdailynews.com

  • Global Cancer Vaccines Research Report 2021-2026: Leading Players are Merck & Co., GlaxoSmithKline and Dendreon
    prnewswire.com

    Global Cancer Vaccines Research Report 2021-2026: Leading Players are Merck & Co., GlaxoSmithKline and Dendreon

    /PRNewswire/ — The

  • 77 Biggest Movers From Yesterday
    markets.businessinsider.com

    77 Biggest Movers From Yesterday

    Gainers Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is exp…

  • Former Penny Stocks To Watch After Merck’s (MRK) Latest FDA Win
    pennystocks.com

  • U.S. COVID-19 case tally passes 36 million as more states seek face-mask mandates and plead with unvaccinated to get shots
    marketwatch.com

    U.S. COVID-19 case tally passes 36 million as more states seek face-mask mandates and plead with unvaccinated to get shots

    The U.S. tally of confirmed cases of COVID-19 passed 36 million on Wednesday, with at least three states gearing up to implement face-mask mandates as they…

  • Why Inovio's Stock Is Trading Lower Today
    markets.businessinsider.com

    Why Inovio's Stock Is Trading Lower Today

    Inovio Pharmaceuticals Inc (NASDAQ:INO) shares are trading lower by 9.9% at $8.65 after the company reported worse-than-expected second-quart…

  • Inovio focused on launching global COVID-19 vaccine trial next month - CEO
    financialpost.com

    Inovio focused on launching global COVID-19 vaccine trial next month – CEO

    Inovio Pharmaceuticals Inc is focused on launching the global late-stage trial of its COVID-19 vaccine candidate next month, chief executive Joseph Kim said in…

  • Inovio Pharmaceuticals, Inc. (INO) CEO Joseph Kim on Q2 2021 Results - Earnings Call Transcript
    seekingalpha.com

    Inovio Pharmaceuticals, Inc. (INO) CEO Joseph Kim on Q2 2021 Results – Earnings Call Transcript

    Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q2 2021 Earnings Conference Call August 9, 2021 16:30 ET Company Participants Ben Matone – Senior Director of Investor Relations Joseph Kim -…

  • Inovio focused on launching global COVID-19 vaccine trial next month - CEO
    financialpost.com

    Inovio focused on launching global COVID-19 vaccine trial next month – CEO

    Inovio Pharmaceuticals Inc is focused on launching the global late-stage trial of its COVID-19 vaccine candidate next month, top boss Joseph Kim said in a call…

  • Inovio Pharmaceuticals : focused on launching global COVID-19 vaccine trial next month - CEO
    marketscreener.com

    Inovio Pharmaceuticals : focused on launching global COVID-19 vaccine trial next month – CEO

    Inovio Pharmaceuticals Inc is
    focused on launching the global late-stage trial of its COVID-19
    vaccine candidate next month, top boss Joseph Kim said in a call
    on Monday, with the drug developer… | August 9, 2021

  • Inovio focused on launching global COVID-19 vaccine trial next month - CEO
    financialpost.com

    Inovio focused on launching global COVID-19 vaccine trial next month – CEO

    Inovio Pharmaceuticals Inc is focused on launching the global late-stage trial of its COVID-19 vaccine candidate next month, Chief Executive Officer Joseph Kim…

  • Earnings Scheduled For August 9, 2021
    benzinga.com

    Earnings Scheduled For August 9, 2021

    Companies Reporting Before The Bell
    • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of …

  • The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
    markets.businessinsider.com

    The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

    Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnin…

  • What Does the Delta Variant Mean for Inovio Pharmaceuticals' Stock?
    fool.com

    What Does the Delta Variant Mean for Inovio Pharmaceuticals' Stock?

    Its vaccine candidate might be too far behind to matter.

  • Novel Vaccine Delivery System Market to Reach $14.43 Billion by 2030: Allied Market Research
    globenewswire.com

    Novel Vaccine Delivery System Market to Reach $14.43 Billion by 2030: Allied Market Research

    Rise in government support and investment, development of novel vaccines, and growth in immunization programs & their increasing coverage drive the growth…

  • INOVIO To Report Second Quarter 2021 Financial Results On August 9, 2021
    thestreet.com

    INOVIO To Report Second Quarter 2021 Financial Results On August 9, 2021

    PLYMOUTH MEETING, Pa., July 26, 2021 /PRNewswire/ — INOVIO INO announced today that second quarter 2021 financial results will be released after the market

  • Is Inovio Pharmaceuticals Primed For a Comeback?
    fool.com

  • Coherus BioSciences Names Physician-Scientist Ildiko Csiki, M.D., Ph.D., Chair Of Its Scientific Advisory Board
    thestreet.com

    Coherus BioSciences Names Physician-Scientist Ildiko Csiki, M.D., Ph.D., Chair Of Its Scientific Advisory Board

    REDWOOD CITY, Calif., July 21, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) today announced the appointment of Ildiko Csiki,

  • Due for a Growth: Inovio Pharmaceuticals Inc. (INO), : StockMarket
    reddit.com

    Due for a Growth: Inovio Pharmaceuticals Inc. (INO), : StockMarket

    1.7m members in the StockMarket community. Welcome to /r/StockMarket! Our objective is to provide short and mid term trade ideas, market analysis & …

  • 5 Heavily Short-Sold Stocks That Won't Squeeze
    fool.com

  • Allied Investment Advisors, LLC Buys Pfizer Inc, Merck Inc, Lockheed Martin Corp, Sells Southwest Airlines Co, Inovio Pharmaceuticals Inc
    gurufocus.com

    Allied Investment Advisors, LLC Buys Pfizer Inc, Merck Inc, Lockheed Martin Corp, Sells Southwest Airlines Co, Inovio Pharmaceuticals Inc

    GuruFocus Article or News written by insider and the topic is about:

  • 3 Small-Cap Stocks With 158% to 329% Upside, According to Wall Street
    fool.com

    3 Small-Cap Stocks With 158% to 329% Upside, According to Wall Street

    Analysts' high-water price targets imply some serious gains for these companies.

  • Best Buy, Inovio Pharmaceuticals, Volkswagen, Ericsson and Nokia highlighted as Zacks Bull and Bear of the Day
    zacks.com

    Best Buy, Inovio Pharmaceuticals, Volkswagen, Ericsson and Nokia highlighted as Zacks Bull and Bear of the Day

    Best Buy, Inovio Pharmaceuticals, Volkswagen, Ericsson and Nokia highlighted as Zacks Bull and Bear of the Day

  • Bear of the Day: Inovio Pharmaceuticals (INO)
    zacks.com

  • Bear of the Day: Inovio Pharmaceuticals (INO)
    investing.com

    Bear of the Day: Inovio Pharmaceuticals (INO)

    Stocks Analysis by Zacks Investment Research covering: Pfizer Inc, ACADIA Pharmaceuticals Inc, Inovio Pharmaceuticals Inc, Moderna Inc. Read Zacks Investment Research's latest article on Investing.com

  • Here's Why Inovio Pharmaceuticals Soared 23% In June
    fool.com

    Here's Why Inovio Pharmaceuticals Soared 23% In June

    Encouraging news reversed what had been a steep sell-off for the clinical-stage biotech.

  • With COVID-19 Variant Threats Rising, Why Are Vaccine Stocks Falling?
    fool.com

    With COVID-19 Variant Threats Rising, Why Are Vaccine Stocks Falling?

    Stock markets moved slightly higher despite general worries.

  • 5 Ultra-Popular Stocks to Avoid Like the Plague in July
    fool.com

    5 Ultra-Popular Stocks to Avoid Like the Plague in July

    Investors should think twice before putting their money to work in these businesses.

  • Esperion Shorts Have Cleaned Up
    gurufocus.com

    Esperion Shorts Have Cleaned Up

    GuruFocus Article or News written by Barry Cohen and the topic is about: In the past year, sellers of most-shorted health care stock reaped 60% gain

  • Inovio's INO-4800 Provides Cross-reactive Immune Responses In Humans Against Variants Of Concern
    markets.businessinsider.com

    Inovio's INO-4800 Provides Cross-reactive Immune Responses In Humans Against Variants Of Concern

    (RTTNews) – Inovio Pharmaceuticals Inc. (INO) said that its DNA vaccine candidate for COVID-19, INO-4800, provided broad cross-reactive immune res…

  • Wasatch Advisors established new holdings in StepStone Group Inc. By Investing.com
    investing.com

    Wasatch Advisors established new holdings in StepStone Group Inc. By Investing.com

    Wasatch Advisors established new holdings in StepStone Group Inc.

  • 2 Investing Mistakes to Avoid Like the Plague in 2021
    fool.com

  • Inovio Strikes $100M Coronavirus Vaccine Licensing Deal With China's Advaccine
    benzinga.com

    Inovio Strikes $100M Coronavirus Vaccine Licensing Deal With China’s Advaccine

    Shares of Inovio Pharmaceuticals Inc (NASDAQ: INO), which is developing a DNA vaccine against the novel coronavirus, were advancing Monday.
    What Happened: …

  • Inovio Pharmaceuticals : partners with Advaccine to make and sell COVID-19 vaccine in China
    marketscreener.com

    Inovio Pharmaceuticals : partners with Advaccine to make and sell COVID-19 vaccine in China

    China’s Advaccine Biopharmaceuticals Suzhou Co Ltd will manufacture and sell Inovio Pharmaceuticals Inc’s COVID-19 vaccine candidate in the country, the companies said on Monday…. | January 4, 2021

  • Inovio to partner with Chinese biotech on COVID-19 vaccine candidate in Greater China
    marketwatch.com

    Inovio to partner with Chinese biotech on COVID-19 vaccine candidate in Greater China

    Shares of Inovio Pharmaceuticals Inc. undefined were up 4.5% in premarket trading on Monday after the company announced a licensing deal with Advaccine…

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

6 ETFs die in Inovio Pharmaceuticals Inc investieren

Dir gefallen die Informationen zu Inovio Pharmaceuticals Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Inovio Pharmaceuticals Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Inovio Pharmaceuticals Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Inovio Pharmaceuticals Inc?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect